The Conference Board uses cookies to improve our website, enhance your experience, and deliver relevant messages and offers about our products. Detailed information on the use of cookies on this site is provided in our cookie policy. For more information on how The Conference Board collects and uses personal data, please visit our privacy policy. By continuing to use this Site or by clicking "OK", you consent to the use of cookies. 
Poison Pills in 2011

Subscribe to Director Notes

Despite the continued decline in the number of outstanding poison pills maintained by U.S. public companies, Delaware courts in several cases in 2010 and early 2011 have steadfastly confirmed the continuing legal vitality of pills that are properly structured, adopted, and administered.

This report discusses these new trends and provides guidance to boards considering whether to adopt a pill and how to formulate its terms.

Pricing
Director Notes (12 pgs)
Complimentary: Sign in or create an account to download.